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Abstract
Background: Severe acute respiratory infections in children can be fatal, rapid identification of the causative agent
and timely treatment can be life saving. Multiplex real time RT-PCR helps in simultaneous detection of multiple viruses
saving cost, time and labour. Commercially available multiplex real time RT-PCR kits are very expensive. Therefore the
aim of the present study was to develop a cost effective multiplex real time RT-PCR for the detection of 18 respiratory
viruses and compare it with an in-vitro diagnostics approved Fast Track Diagnostic Respiratory Pathogens 21 Kit (FTD).
Methods: Nasopharyngeal aspirates and throat swabs were collected and processed for extraction of nucleic acid
using an automated extraction system and multiplex real time RT-PCR was performed using the FTD kit and a custom
assay on 356 samples.
Results: Custom and FTD assays detected one or more respiratory viruses in 268 (75.29 %) and 262 (73.60 %) samples
respectively. The concordance between the custom assay and the FTD assay was 100 % for HCoV OC43, HCoV 229E,
HPIV-1, HPIV-2, HBoV, HPeV, Flu A, and Influenza A(H1N1)pdm09 and 94.66 – 99.71 % for the remaining viruses; Flu B
(99.71 %), HRV (99.71 %), HPIV-3 (98.87 %), HPIV-4 (99.43 %), HCoV NL63 (99.71 %), HMPV A/B (99.71 %), RSV A/B
(94.66 %), EV (98.31 %), HCoV HKU1 (99.71 %), HAdV (99.71 %). Major discrepancy was observed for RSV A/B, which
was over detected in 18 samples by the custom assay as compared to the FTD assay. The custom assay was much
cheaper than the FTD assay and the time taken was only 29 min more.
Conclusion: The custom primer and probe mix was found to be comparable to the FTD assay with good concordance
but was much cheaper and the time taken for reporting was only 29 min more. The low cost custom multiplex RT-PCR
can be a useful alternative to the costly FTD kit for rapid identification of viral aetiology in resource limited settings.
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Background
Severe acute respiratory infections (SARI) are one of the
major causes of illness and death worldwide and are the
third most common cause of death among children [1].
Acute respiratory infections (ARI) cause more deaths in
children < 5 years with most cases reported from India
(43 million), China (21 million), Pakistan (10 million),
Bangladesh, Indonesia and Nigeria (56 million) [2]. Re-
spiratory infections can be caused by many viruses, both
DNA and RNA. These include the Respiratory Syncytial
Virus (RSV), human Parainfluenza Virus (HPIV), Influ-
enza A Virus (Flu A), Influenza B Virus (Flu B), human
Adenovirus (HAdV), human Coronavirus (HCoV), human
Rhinovirus (HRV), human Metapneumovirus (HMPV)
and human Bocavirus (HBoV) [3]. A new wave of viral
diagnosis was established with the development of Poly-
merase Chain Reaction (PCR) techniques in the 1990s [4].
PCR is more sensitive and rapid than conventional
methods for detection of respiratory viruses. Different
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respiratory viruses present with similar signs and symp-
toms and can’t be differentiated symptomatically or clinic-
ally. Tests capable of rapid simultaneous identification of
various viruses at the same time can help expedite initi-
ation of appropriate therapy. Uniplex RT-PCR requires
individual amplification of each virus under study which is
expensive, time consuming and laborious [5]. To overcome
this, multiplex real-time PCRs targeting the detection of
multiple pathogens simultaneously have been developed
commercially but they are very expensive. There is a need
to develop cheaper systems for rapid simultaneous identifi-
cation of various viruses. The present study compares cus-
tom real-time multiplex PCR primers and probes for the
simultaneous detection of 18 respiratory viruses with an




Children with SARI, admitted in J. K. Lone Hospital, a
pediatric hospital attached to Sawai Man Singh (SMS)
Medical College Jaipur were enrolled in the study and
tested for respiratory viruses with prior consent of the
parent/guardian. Duration of the study was 27 months
i.e. between September, 2012 to December, 2014. Chil-
dren enrolled were ≤ 5 years of age, presenting with
fever, cough, sore throat, nasal catarrh, shortness of
breath, bronchiolitis, pneumonia, and wheezing.
Patient exclusion criteria
Samples were not collected from patients with chronic
respiratory ailments; non-consenting caregivers, with
history of hospitalization in the preceding 14 days, not
admitted in hospital and children aged > 5 years.
Sample collection and transportation
A total of 356 nasopharyngeal aspirate and throat swab
samples were collected from patients with SARI by a
trained technician using a sterile nylon flocked swab and
placed in viral transport medium (VTM), labelled and
transported on ice at the earliest to Advanced research
lab (ICMR Grade-1 Virology Lab) of SMS Medical col-
lege Jaipur for further processing and storage of the
samples. The study was approved by the institutional
ethics committee.
Nucleic acid extraction
Viral nucleic acid from samples was extracted using an
EasyMAG (Biomeurex) automated extractor according
to the manufacturer’s instructions. Briefly, the extrac-
tion was done from 400 μl homogenised sample which
was added to 1500 μl lysis buffer and was incubated for
10 min off board. The samples were loaded into the
EasyMAG and 100 μl of magnetic silica was added to
each sample and mixed well. Finally, the nucleic acid
was eluted in a volume of 110 μl of which 50 μl was
used for the FTD assay and 54 μl for the custom assay.
Multiplex real -time RT-PCR (FTD ASSAY)
The multiplex real-time PCR FTD assay was performed
on an ABI 7500 Fast instrument (Life Technologies,
USA) as per the manufacturer’s instructions using an
AgPath-ID ™One-Step RT-PCR kit (Ambion) with the
FTD Respiratory pathogens 21 kit (Fast Track Diagnosis,
Luxembourg) for the detection of 18 viruses using five
tubes containing primer and probe mix for different vi-
ruses; Tube-1 [Influenza A (Flu A), Influenza A subtype
H1N1 (Pandemic H1N1), human Rhinovirus (HRV), Influ-
enza B (Flu B)], Tube-2 [human Coronaviruses NL63
(HCoV-NL63), 229E (HCoV 229E), OC43 (HCoV-OC43),
and HKU1 (HCoV HKU1)], Tube-3 [human Parainfluenza
viruses, 2, 3, and 4 (HPIV- 2, 3 and 4) & IC], Tube-4 [hu-
man Parainfluenza viruses-1, Mycoplasma pneumoniae
(M.pneu), human Bocavirus (HBoV), human Metapneu-
movirus (HMPV A/B)] and Tube-5 [Respiratory Syncytial
virus (RSVA/B), human Adenovirus (HAdV), Enterovirus
(EV), human Parechovirus (HPeV)]. The multiplex real
time RT-PCR thermal profile for the FTD kit was as fol-
lows; 50 °C for 15 min, 95 °C for 10 min, 40 cycles of 95 °C
for 8 s, 60 °C for 34 s, whereas the thermal profile for the
custom assay was set at 50 °C for 30 min, 95 °C for
10 min, 45 cycles of 95 °C for 15 s, 55 °C for 30 s.
Standardisation of uniplex real-time PCR (Custom assay)
Initial standardisations were done for uniplex real-time
PCR using the FTD positive samples as controls. These
positive samples included the following viruses namely,
HRV, HAdV, Flu A, Pandemic H1N1, Flu B, HPIV-1,
HPIV-2, HPIV-3, HPIV-4, RSVA/B, HMPVA/B, HPeV, EV,
HCoV-OC43, HCoV-NL63, HCoV 229E, HCoV HKU1,
(HBoV). AgPath (Ambion) one step RT-PCR master mix
was used for the amplification and detection of viral nu-
cleic acid. Briefly, each reaction was performed in a 20 μl
volume which consisted of 12.5 μl of buffer, 1 μl of enzyme,
2 picomoles of each primer (corresponding to each virus),
2 picomoles of probe (corresponding to each virus) (syn-
thesised by Life Technologies) (Table 1), 5 μl of extracted
nucleic acid of the positive control/sample and made to a
final volume of 20 μl with nuclease free water. The thermal
cycling profile for the uniplex RT-PCR was 50 °C for
30 min (1 cycle), 95 °C for 10 min (1 cycle) followed by
90 °C for 15 s and 55 °C for 30 s (45 cycles). Specimens
were considered positive when the Ct value was < 35.
Standardisation of multiplex real-time RT-PCR
(Custom assay)
Uniplex PCR was followed by multiplex real-time RT-
PCR standardisation. In multiplex PCR, each reaction
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Table 1 Custom primers and probes used for the detection of respiratory viruses
VIRUS Froward primer (5’ - 3’) Reverse primer (5’ - 3’) Probe (5’ - 3’)d References
Panel-1
Flu B GAGACACAATTGCCTACCTGCTT TTCTTTCCCACCGAACCAAC aFAM – AGAAGATGGAGAAGGCA AAG CAGA ACTAGC Esposito et al., 2010 [17]
HCoV 229E CAGTCAAATGGGCTGATGCA AAAGGGCTATAAAGAGAATAAGGTATTCT bVIC – CCCTGACGACCACGTTGTGGTTCA Hammit et al., 2011 [6]
HCoV OC43 CGATGAGGCTATTCCGACTAGGT CCTTCCTGAGCCTTCAATATAGTAACC cNED-TCCGCCTGGCACGGTACTCCCT Hammit et al., 2011 [6]
Panel-2
HPIV-4 CAGAYAACATCAATCGCCTTACAAA TGTACCTATGACTGCCCCAAARA aFAM – CCMATCACAAGCTCAGAAATYCAAAGTCGT Hammit et al., 2011 [6]
HPIV-1 GTGATTTAAACCCGGTAATTTCTCA CCTTGTTCCTGCAGCTATTACAGA bVIC- ACCTATGACATCAACGAC Hammit et al., 2011 [6]
HPIV-3 CCAGGGATATAYTAYAAAGGCAAAA CCGGGRCACCCAGTTGTG cNED – TGGRTGTTCAAGACCTCCATAYCCGAGAAA Hammit et al., 2011 [6]
Panel-3
Influenza A(H1N1) pdm09 GTGCTATAAACACCAGCCTYCCA CGGGATATTCCTTAATCCTGTRGC aFAM - CAGAATATACATCCRGTCACAATTGGARAA WHO, 2009 [22]
HRV TGGACAGGGTGTGAAGAGC CAAAGTAGTCGGTCCCATCC bVIC - TCCTCCGGCCCCTGAATG Hammit et al., 2011 [6]
HPIV-2 ATGAAAACCATTTACCTAAGTGATGGA CCTCCYGGTATRGCAGTGACTGAAC cNED - TCAATCGCAAAAGC Hammit et al., 2011 [6]
Panel-4
RSV A/B GGAAACATACGTGAACAAGCTTCA RSV-A: CATCGTCTTTTTCTAAGACATTGTATTGA aFAM – TGTGTATGTGGAGCCTT Kwofie et al., 2012 [10]
RSV-B: TCATCATCTTTTTCTAGAACATTGTACTGA
HCoV NL63 ACGTACTTCTATTATGAAGCATGATATTAA AGCAGATCTAATGTTATACTTAAAACTACG bVIC –ATTGCCAAGGCTCCTAAACGTACAGGTGTT Hammit et al., 2011 [6]
HCoV HKU1 AGTTCCCATTGCTTTCGGAGTA CCGGCTGTGTCTATACCAATATCC cNED - CCCCTTCTGAAGCAA Cui et al., 2011 [11]
Panel-5
EV CCCTGAATGCGGCTAATCC ATTGTCACCATAAGCAGCCA aFAM- AACCGACTACTTTGGGTGTCCGTGTTTC Wolffs et al., 2011 [23]
HPeV GTAACASWWGCCTCTGGGSCCAAAAG GGCCCCWGRTCAGATCCAYAGT bVIC- CCTRYGGGTACCTYCWGGGCATCCTTC Nix et al., 2008 [12]
HBoV TGCAGACAACGCYTAGTTGTTT CTGTCCCGCCCAAGATACA cNED – CCAGGATTGGGTGGAACCTGCAAA Sanghvi et al., 2012 [22]
Panel-6
Flu A GACCRATCCTGTCACCTCTGAC AGGGCATTYTGGACAAAKCGTCTA aFAM – TGCAGTCCTCGCTCACTGGGCACG WHO, 2009 [22]
HAdV GCCCCAGTGGTCTTACATGCACATC GCCACGGTGGGGTTTCTAAACTT bVIC – TGCACCAGACCCGGGCTCAGGTACTCCGA Hammit et al., 2011 [6]
HMPV A/B CATCAGGTAATATCCCACAAAATCAG GTGAATATTAAGGCACCTACACATAATAARA cNED - TCAGCACCAGACACAC Sanghvi et al., 2012 [13]
NOTE: The lower limit for the detection of HBoV- 1 DNA copy/ml, HMPV- 30 Rna copies/ml, HPeV- 103 (cell culture infective dose) CCID50 - 10
4 CCID50, RSV A/B- 2×10
4copies/μl, HCoV HKU1- 5×103 copies/ml, Flu B- 2.2
Log10 (viral particles) VP/ml, and Influenza A(H1N1)pdm09 - 2×10
1 to 2×copies/ml
aFAM - Detection wavelength - 518 nm; bVIC detection wavelength - 554 nm; cNED detection wavelength 575 nm










was targeted for the simultaneous detection of three dif-
ferent viruses in a single reaction tube. Each reaction mix
consisted of respective forward and reverse primers, and
probes each labelled with a different fluorescent dye
(FAM, VIC and NED) specific to each of the three viruses.
Tube-1 [Influenza B (Flu B), human Coronaviruses229E
(HCoV 229E), OC43 (HCoV-OC43)], Tube-2 [human
Parainfluenza viruses, 1, 3, and 4 (HPIV- 1, 3 and 4)],
Tube-3 [Influenza A subtype H1N1 (Pandemic H1N1),
human Rhinovirus (HRV), human Parainfluenza viruses-1
(HPIV-1)], Tube-4 [Respiratory Syncytial virus (RSVA/B),
human Coronaviruses NL63 (HCoV-NL63), HKU1 (HCoV
HKU1)], Tube-5 [Enterovirus (EV), human Parechovirus
(HPeV), human Bocavirus (HBoV)], Tube-6 [Influenza A
(Flu A), human Adenovirus (HAdV), human Metapneu-
movirus (HMPV A/B)]. FTD positive samples were con-
sidered as standard. AgPAth (Ambion) one step RT-PCR
master mix was used for the detection of respective viral
nucleic acids as mentioned above in a reaction volume of
25 μl but with 9 μl of nucleic acid, 4 picomoles of each
primer and 2 picomoles of probe. The thermal profile for
the multiplex real-time PCR was as described above.
Specimens were considered positive when the Ct value
was < 35. After standardisation of multiplex PCR the
same protocol was used for screening patient samples.
Rnase P was used as an internal control in a separate
uniplex RT PCR assay. Samples negative for Rnase P
were not included in the study.
Results
A total of 356 samples were tested by both assays. Cus-
tom and FTD assays detected one or more respiratory
viruses in 268 (75.29 %) and 262 (73.60 %) samples re-
spectively (Table 2).
No significant differences were seen in the number of
samples positive for each virus by the custom assay as
compared to the FTD assay except with RSV A/B which
was over detected in 18 samples and one sample being
under detected by the custom assay as compared to the
FTD assay. Further, to completely assess the results of
these 18 discordant RSVA/B samples, testing was re-
peated using RSV A and RSV B specific primer and
probe mix in uniplex real time RT- PCR as published
previously [6]. All 18 samples were found to be positive
for RSV B (Table 3).
One hundred percent concordance was observed be-
tween the custom assay and the FTD assay for eight vi-
ruses; HCoV OC43, HCoV 229E, HPIV-1, HPIV-2, HBoV,
HPeV, Flu A, and Influenza A(H1N1)pdm09 while it var-
ied from 94.66 to 99.71 % for the remaining ten viruses;
Flu B, HRV, HPIV-3, HPIV-4, HCoV NL63, HMPV A/B,
RSVA/B, EV, HCoV HKU1, HAdV. (Table 4).
Low concordance was observed between the two as-
says for RSV A/B (94.66 %) and EV (98.31 %).
The discordant results of the custom assay were seen in
19 co-infection samples, 13 single infection samples and
four negative samples as compared to the FTD assay, and
the discordance was predominant in the co-infected sam-
ples as compared to single infection samples (Table 5).
Comparisons between the custom assay and the FTD
assay were made based on the different parameters listed
in Table 6. Most of the findings between the custom
assay and the FTD assay were similar except for the cost
incurred for screening 18 respiratory viruses. In this re-
gard, the custom assay was found to be more econom-
ical than the commercial FTD assay.
Table 2 Single and multiple infections detected by custom
assay as compared to FTD assay
Number of viruses detected Custom assay FTD assay
0 88 (24.71 %) 94 (26.40 %)
1 197 (55.33 %) 203 (57.02 %)
2 65 (18.25 %) 55 (15.44 %)
3 6 (1.68 %) 4 (1.12 %)
Table 3 Typing results of RSV A & RSV B for samples positive by
custom assay
RSV A RSV B RSV A & B (co-infections) Total
0/18 18/18 0/18 18/18











HCoV OC43 7 0 0 100.0
HCoV 229E 3 0 0 100.0
Flu B 12 0 1 99.71
HPIV-1 6 0 0 100.0
HPIV-3 22 1 3 98.87
HPIV-4 5 1 1 99.43
HPIV-2 5 0 0 100.0
HCoV NL63 2 1 0 99.71
HMPV A/B 42 1 0 99.71
RSV A/B 66 1 18 94.66
HBoV 16 0 0 100.0
HPeV 1 0 0 100.0
HRV 65 0 1 99.71
EV 8 2 4 98.31
HCoV HKU1 2 1 0 99.71
HAdV 26 0 1 99.71
Flu A 2 0 0 100.0
Influenza
A(H1N1)pdm09
27 0 0 100.0
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Discussion
The present study was performed to compare a custom
multiplex assay and an FTD multiplex assay by testing
of 356 respiratory samples obtained from children with
SARI admitted in J K lone paediatric hospital Jaipur.
In the present study, the concordance between the cus-
tom assay and the FTD assay was found to be 100 % for
Flu A, Influenza A(H1N1) pdm09, HCoV OC43, HCoV
229E, HPIV-1, HPIV-2, HBoV, and HPeV. Similarly Chen
et al., [7] reported a concordance of 99.60 % for Flu A and
Influenza A(H1N1) pdm09 when comparing a multiplex
PCR assay with a uniplex assay.
The concordance between the two assays varied from
94.66 to 99.71 % for the remaining ten viruses; Flu B
(99.71 %), HPIV-3 (99.71 %), HPIV-4 (99.43 %), HCoV
NL63 (99.71 %), HMPVA/B (99.71 %), RSVA/B (94.66 %),
HCoV HKU1 (99.71 %), HAdV (99.71 %), HRV (99.71 %),
EV (98.31 %). Similar findings have been observed in
earlier studies for Flu B (98.25 to 99.42 %), HPIV-3 (96.53
to 99.30 %), HPIV-4 (97.10 %), HCoV NL63 (95.95 to
100.0 %), HMPV A/B (99.65 to 100.0 %), RSV A/B (93.06
to 98.60 %), HCoV HKU1 (98.84 to 100.0 %), HAdV
(97.20 to 100.0 %) [8, 9]. Concordance for EV in the
present study was different from an earlier study (93.00 %)
[8]. The difference in concordance obtained in different
studies may be due to the different primer binding regions
or may be due to different methodologies employed by
various studies. The number of samples positive for HCoV
Table 5 Discordant results of custom and FTD assays
Custom assay FTD assay Number of
samples
RSV A/B NEGATIVE 07
HBoV + RSV A/B HBoV 02
HRV + RSVA/B HRV 02
EV + RSV A/B EV 01






HMPVA/B + RSV A/B HMPVA/B 01
Flu B + RSV A/B Flu B 01
HPIV-3 + RSV A/B HPIV-3 01
HPIV-3 + HRV HRV 01
HBoV + HPIV-3 HBoV 01
aHPIV-4 + HRV aHPIV-3 + HRV 01
EV NEGATIVE 02
NEGATIVE EV 01
HBoV HBoV + EV 01
HCoV OC43 HCoV OC43+ HCoV HKU1 01
HRV + HAdV HRV 01
HPIV-2 + Flu B HPIV-2 01
HPIV-3 NEGATIVE 01
NEGATIVE HPIV-4 01
NEGATIVE HCoV NL63 01
HPIV-3 HPIV-3 + HMPVA/B 01
Influenza A(H1N1)pdm09 + EV Influenza A(H1N1)pdm09 01
HRV + RSVA/B HRV 01
NEGATIVE RSV A/B 01
HRV + EV HRV 01
aThis sample is counted as variation of co-infection on both the sides
Table 6 Comparison of custom and FTD assay in regard to
sample testing
Custom assay FTD assay











RSV A/B RSV A/B







Sample volume 200 μl 200 μl
Elution volume 55 μl 55 μl
PCR volume 25 μl 25 μl




Hands on time 50 min 50 min
Time to result 3.5 h 3.01 h
Total cost per sample INR 1500 INR 4300
Ease of Handling + +
Equipment NucliSENS EasyMAG,
ABI 7500 DX Fast
NucliSENS EasyMAG,
ABI 7500 DX Fast
No. of PCR tubes used
per sample
6 5
Primers & probes Custom assay (ABI) FTD
Number of targets/tube 3 4
PCR reaction volumes
2X RT-PCR buffer 12.5 μl 12.5 μl
25X RT-PCR enzyme 1.0 μl 1.0 μl
Primer probe mix/tube 1.8 μl 1.5 μl
Nucleic acid 9 μl 10 μl
Nuclease free water 0.7 μl –
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229E, HPIV-4, HPIV-2, HCoV NL63, HPeV, HCoV HKU1,
Flu A, were ≤ 5 in the present study. Studies based on lar-
ger numbers of samples are required to assess the con-
cordance of these viruses more thoroughly.
The limit of detection for some of the viruses in the
custom assay (Table 7) ranged from 1 DNA copy/ml to
2×104 copies/ml [7, 10–14]. The detection limit of the
FTD assay for different viruses was 102 copies/ml for
FluA, HPIV-2, HMPV and HCoV OC43; 103 copies/ml
for FluB, HCoV HKU1, HPIV-1, HBoV, HPIV-3, HCoV
NL63, RSV, HAdV, EV, and HPeV; and 104 copies/ml for
HRV, HCoV 229E and HPIV-4 [15].
In the present study RSV A/B was the most predomin-
ant virus detected by both the custom and FTD assays
with positivity in 84 (23.60 %) and 67 (18.82 %) samples
respectively and concordance of 94.66 %. This finding is
different when compared with other studies [8, 16]
where comparisons were made between multiplex PCRs
in which RSV was the second most predominant virus
detected [16].
The custom primer and probes used for Influenza
A(H1N1) pdm09, RSV A/B, Flu B, HMPV A/B, HBoV,
HRV, HPIV-1-4, HAdV and HCoVs showed a positivity
of 7.58, 23.60, 3.65, 11.80, 4.49, 18.54, 11.79, 7.58 and
3.93 % respectively for each virus in the present study in
comparison to a positivity of 18.39 % [7], 14.1 % [10],
13.3 % [17], 2.9 % [13], 0.5–4.5 % [13, 18, 19], 20.78 %
[6], 8.62 % [6], 3.5 % [20], and 4.70 % [6] respectively in
earlier studies where the same primer and probes were
used. HBoV was mostly associated with co-infections in
the present study in both assays. This is consistent with
an earlier study [16]
The major discrepancy in the present study was found
with RSV A/B. The discrepancy in 18 samples which
were over detected by the custom assay was resolved by
RSV A and RSV B typing. The RSV typing results for the
discrepant samples showed that all 18 samples were
RSV B. Further all samples positive for RSV A/B by the
FTD assay were also subjected to RSV typing which in-
dicated RSV A in 13 (19.40 %) samples, RSV B in 50
(74.63 %) samples and RSV A & RSV B dual infections
in 4 (5.97 %) samples
During the process of standardisation of the custom
assay 3 μl of viral nucleic acid (positive control) was
used for each virus including 4 picomoles of primers
and 2 picomoles of probes. Each panel consisted of 3 vi-
ruses. In total 9 μl of viral nucleic acid was used for each
panel. While the FTD assay used 10ul of nucleic acid in
each tube with primers and probes for 4 viruses, the
concentration of primer and probe was not disclosed by
FTD. In total 4 μl more of viral nucleic acid was used in
the custom assay compared to the FTD assay which may
have increased the sensitivity/detection of different vi-
ruses in the custom assay.
Initially during the process of standardisation of the cus-
tom assay, different primer and probe concentrations were
tried and the PCR was run for 45 cycles as per the proto-
col followed by various authors. Although data was ana-
lysed using PCRs run for 35 and 40 cycles, best results
were achieved using a Ct value of 35 for both the FTD
assay and the custom assay. Accordingly, a Ct value of
<35 was considered as positive for both assays as per the
FTD kit. With the custom assay being run for 40 cycles
this reduces the custom assay run time by 8 min, thereby
making it only 21 min longer than the FTD assay.
Comparisons were made between various aspects of the
custom and the FTD assays (Table 6). No major differ-
ences were observed between the two assays except in the
cost incurred for both assays. Similar comparisons were
also done in an earlier study [21] where three multiplex
PCRs were compared. The turn-around time of the cus-
tom assay was 29 min more as compared to the FTD
assay. But both the assays reported the results on the same
day. The excess time of 29 min taken by the custom assay
as compared to the FTD assay may not greatly interfere
with the treatment process. However, the custom assay
was much more economical costing INR 1500/- per sam-
ple for screening 18 respiratory viruses compared to the
commercial FTD assay which was expensive costing INR
4300/- per sample. This assay may prove to be highly cost
effective in resource limited settings like ours. However
the limitation of our study was that some of the viruses
showed low positivity as a result it is difficult to assess the
concordance accurately. Larger numbers of positive sam-
ples need to be tested to evaluate the concordance of
these less prevalent viruses.
Conclusion
This study reported a high prevalence of respiratory vi-
ruses in children ≤ 5 years using a custom assay and an
FTD assay. Good concordance was observed for all the
viruses between both assays except for RSVA/B. How-
ever larger numbers of positive samples need to be
tested for thorough evaluation of less prevalent viruses.
Table 7 Detection limits of different respiratory viruses by
custom assay and FTD kit
Name of the virus Custom assay detection limit FTD assay detection
limit
HBoV 1 DNA copy/ml [13] 103 copies/ml
HMPV 30 RNA copies/ml [13] 102 copies/ml
HPeV 103 CCID50 - 10
4 (CCID50 [12] 10
3 copies/ml
RSV A/B 2 × 104 copies/ml [10] 103 copies/ml
HCoV HKU1 5 × 103copies/ml [11] 103 copies/ml




2 × 101 to 2 × 102 copies/ml [7] 103 copies/ml
Malhotra et al. Virology Journal  (2016) 13:91 Page 6 of 7
The custom primer and probe mix was much more eco-
nomical than the commercial FTD kit. Our study suggests
that this custom multiplex real-time RT-PCR can be used
for simultaneous and rapid detection of multiple viruses
in resource limited settings. This will help prevent un-
necessary use of antibiotics and permit timely initiation of
supportive therapy/antiviral drugs if available.
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